OTTAWA—Pfizer Canada delivered a bleak view of Canada’s depleted vaccine manufacturing capacity Monday, saying the company recently rejected Ottawa’s pitch to even finish off the last step in the production here on Canadian soil. Pfizer Canada president Cole Pinnow told the Commons health committee that the Liberal government did try to negotiate domestic manufacturing of the vaccine. Later a Pfizer spokesperson declined to identify which Canadian sites the company rejected. Loading... Loading... Loading... Loading... Loading... Loading...Pfizer and BioNTech invested $2 billion to develop its vaccine in record time, and to scale up production, he said. The Canadian company licensed its intellectual property to Pfizer, he said.

Source: thestar March 09, 2021 00:00 UTC